Edition:
United States

Profile: West Pharmaceutical Services Inc (WST)

WST on New York Consolidated

81.15USD
30 Nov 2016
Change (% chg)

-- (--)
Prev Close
$81.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
372,430
52-wk High
$84.33
52-wk Low
$53.88

West Pharmaceutical Services, Inc. (West), incorporated on July 27, 1923, is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company's segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). The Company's products include stoppers and seals for vials, and contract design and manufacturing services. The Company's customers include producers of pharmaceuticals, biologics, medical devices and consumer products.

Packaging Systems Segment

The Company's Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, including stoppers and seals for vials, closures and other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. The Packaging Systems consists of three segments: Americas, Europe and Asia Pacific. The Company's Packaging Systems' products generally consist of elastomeric components offered in various standard and customer-specific configurations and formulations, which are available with advanced barrier films and coatings to enhance their performance. West FluroTec barrier film is applied to reduce the risk of product loss by contamination and protect the shelf life of packaged drugs. The Company also applies a Teflon coating to the surface of stoppers and plungers to improve compatibility between the closure and the drug. B2-coating is a coating applied to the surface of stoppers and plungers using a process that eliminates the need for conventional silicone application. It helps manufacturers reduce product rejections due to trace levels of silicone molecules found in non-coated packaged drug compounds.

The Company's Westar RS and Westar RU post-manufacturing processes are the procedures for washing, siliconizing and sterilizing stoppers and syringe components. The Westar RS process prepares components for introduction into the customer's sterilizer and the Westar RU process provides sterilized components. These processes increase the overall efficiency of injectable drug production by outsourcing component processing. The Company also offers Envision components that are inspected using automated vision inspection systems for visible and subvisible particulate and contamination.

The Company's NovaPure components include serum and lyophilization stoppers and syringe plungers. The Company's tamper-evident Flip-Off seals are sold in various ranges of sizes and colors for product identification and differentiation. The Company's sterile drug vial seal, the Flip-Off Plus seal, offers safe container integrity for drug products while minimizing levels of bioburden and particulates. The Company offers contract analytical laboratory services for testing and evaluating primary drug-packaging components and their compatibility with the contained drug formulation. Its analytical laboratories also provide specialized testing for complete drug delivery systems.

Delivery Systems Segment

The Company's Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions targeted to the healthcare and consumer-products industries. Delivery Systems Segment focuses on product design and development, including in-house mold design and construction, an engineering center for developmental and prototype tooling, process design and validation and automated assemblies. In addition, Delivery Systems is also engaged in the development and commercialization of its line of healthcare, administrative and advanced injection systems, including Daikyo CZ, SmartDose and other systems.

The Company's Delivery Systems' products include Daikyo CZ 1 milliliter long Insert Needle syringe system, which is a polymer syringe system without silicone oil lubrication applied to the barrel or plunger that incorporates an insert-molded needle to avoid the need for adhesive. The Company's ConfiDose auto-injector and SelfDose self-injection systems eliminates preparation steps and improves the injection of drugs, providing patients with a sterile, single-use disposable system that can be readily used at home. The Company's administration systems include sterile devices for the preparation and administration of drug products, including products, such as the MixJect transfer device, the Mix2Vial needleless reconstitution system, the Vial2Bag system and various vial adapters. Its safety systems, which are designed to prevent needle sticks, are eris and NovaGuard SA for prefilled syringes and NovaGuard LP for luer lock syringes. The Company offers customer contract-manufacturing and assembly solutions, which uses such technologies as multi-component molding, in-mold labeling, ultrasonic welding and clean room molding and device assembly used to manufacture customer-owned components and devices used in surgical, diagnostic, ophthalmic, other drug delivery systems and consumer products.

Company Address

West Pharmaceutical Services Inc

530 HERMAN O WEST DR
EXTON   PA   19341-1147
P: +1610.5942900
F: +1800.3459800

Company Web Links